Investment
Features
FeesSafety
Academy
More
Pluang+

DWS Investment reduces its direct voting rights in Umicore below 3%.

Market News
23 Mar 2026
GlobeNewsWire
View Source
Neutral
pluang ai news

DWS Investment GmbH has notified Umicore that it lowered its direct voting rights from above 3% to 2.76% as of March 16, 2026. This change triggers a transparency notification under the law requiring disclosure of major holdings. The reduction reflects a disposal or acquisition of voting securities. Umicore, a global leader in advanced materials and recycling, continues to operate with a focus on sustainable value creation and clean technologies.

More News

Global automotive microcontrollers market to reach $34.31B by 2035, driven by ADAS, electrification, and software-defined vehicles.

Global automotive microcontrollers market to reach $34.31B by 2035, driven by ADAS, electrification, and software-defined vehicles.

The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...

Market News
Bullish
2 hours ago
UnitedHealth beats Q2 earnings estimates, raises 2026 profit outlook with AI-driven cost control.

UnitedHealth beats Q2 earnings estimates, raises 2026 profit outlook with AI-driven cost control.

UnitedHealth Group reported second-quarter earnings that surpassed expectations, driven by better management of high medical costs and AI investments to streamline operations. The company raised its 2026 adjusted earnings forecast to $19.50-$20 per s...

Company Fundamentals
Bullish
4 hours ago
Meta Platforms upgraded to buy on cloud business entry and strong cash flow outlook

Meta Platforms upgraded to buy on cloud business entry and strong cash flow outlook

Meta Platforms has been upgraded to a buy rating due to its new cloud business, which is expected to stabilize cash flow and improve profitability. Despite heavy capital expenditures, Meta maintains strong free cash flow margins and operational effic...

Analyst Insights
Bullish
4 hours ago
Alnylam Pharmaceuticals rated BUY despite recent stock drop, backed by strong drug sales and solid finances.

Alnylam Pharmaceuticals rated BUY despite recent stock drop, backed by strong drug sales and solid finances.

Willow Tree Research initiates coverage of Alnylam Pharmaceuticals with a non-consensus BUY rating, viewing the recent stock price decline as an overreaction. The company’s drug AMVUTTRA holds a near-term commercial monopoly in TTR silencing, with st...

Analyst Insights
Bullish
4 hours ago
SpaceX stock dips below IPO price amid investor concerns over losses and valuation.

SpaceX stock dips below IPO price amid investor concerns over losses and valuation.

SpaceX shares fell below their IPO price of $135 for the first time, dropping to $132.28 before closing slightly above at $135.27. The stock is down about 16% from its June 12 closing price and 36% from its peak on June 16. The decline reflects inves...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App